Literature DB >> 1907918

Framework peptides from kappa IIIb rheumatoid factor light chains with binding activity for aggregated IgG.

F C Hay1, A J Soltys, G Tribbick, H M Geysen.   

Abstract

Most monoclonal human rheumatoid factors (RF) and some RF from rheumatoid patient's synovia are restricted in their light chains, using predominantly the kappa IIIb subfamily. Very few sequence differences are found between these light chains. Light chains with similar variable region framework sequences are also found in some mouse monoclonal RF derived from mice stimulated with lipopolysaccharide or secondarily immunized with protein antigens. There are two likely explanations for this restriction in framework sequences between the two species: (a) the sequences are important for the immunoregulation of RF production or (b) the sequences are concerned with the antibody binding specificity of the RF. We have examined overlapping octapeptides from the kappa IIIb light chain variable region and show that some framework peptides have the ability to bind aggregated IgG. Replacement of amino acids within the peak binding peptide have indicated the critical amino acids necessary for binding.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907918     DOI: 10.1002/eji.1830210809

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Rheumatoid factors: where are we now?

Authors:  A I Soltys; J S Axford; B J Sutton
Journal:  Ann Rheum Dis       Date:  1997-05       Impact factor: 19.103

2.  Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments.

Authors:  Y Ichiyoshi; P Casali
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

3.  Primary sequence and location of the idiotopes of V-88, a DNA-binding monoclonal autoantibody, determined by idiotope scanning with synthetic peptides on pins.

Authors:  N A Staines; F J Ward; A N Denbury; J Mitchiner; O Hartley; D Eilat; D A Isenberg; S Bansal
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

4.  Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors.

Authors:  L Mantovani; R L Wilder; P Casali
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

5.  Human combinatorial antibody libraries to hepatitis B surface antigen.

Authors:  S L Zebedee; C F Barbas; Y L Hom; R H Caothien; R Graff; J DeGraw; J Pyati; R LaPolla; D R Burton; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

6.  Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli beta-galactosidase.

Authors:  N Harindranath; H Ikematsu; A L Notkins; P Casali
Journal:  Int Immunol       Date:  1993-12       Impact factor: 4.823

7.  Catalytic activity of anti-ground state antibodies, antibody subunits, and human autoantibodies.

Authors:  S Paul
Journal:  Appl Biochem Biotechnol       Date:  1994 May-Jun       Impact factor: 2.926

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.